Thromb Haemost 1993; 69(05): 415-417
DOI: 10.1055/s-0038-1651625
Original Article
Clinical Studies
Schattauer GmbH Stuttgart

Lack of Association Between Antiphospholipid Antibodies and Migraine

D A Tsakiris
1   The Coagulation and Fibrinolysis Laboratory, University Hospital of Basel, Switzerland
,
L Kappos
2   Department of Neurology, University Hospital of Basel, Switzerland
,
G Reber
3   Haemostasis Unit, University Cantonal Hospital, Geneva, Switzerland
,
G A Marbet
1   The Coagulation and Fibrinolysis Laboratory, University Hospital of Basel, Switzerland
,
J Le Floch-Rohr
4   Department of Neurology, University Cantonal Hospital, Geneva, Switzerland
,
E Roux
5   Division of Rheumatology, University Cantonal Hospital, Geneva, Switzerland
,
P de Moerloose
3   Haemostasis Unit, University Cantonal Hospital, Geneva, Switzerland
› Author Affiliations
Further Information

Publication History

Received 12 October 1992

Accepted after revision 21 December 1992

Publication Date:
25 July 2018 (online)

Preview

Summary

We prospectively studied the prevalence of lupus anticoagulant, anticardiolipin antibodies (aCL) and various haemostatic parameters in 71 patients with migraine and compared the results with a control group of 32 subjects with back pain never having experienced migraine. The patients with migraine were divided into two groups: group I with migraine without (n = 18) and with aura lasting less than 60 min (n = 24) and group II with migraine with prolonged aura or migrainous infarction (complicated migraine, n = 29). The following results were obtained: a) no difference in aCL positivity was noted between migrainous patients and controls and between common migraine and complicated migraine patients and b) no statistically significant difference in haemostatic parameters (except for thrombin-antithrombin III complexes) was found between the two groups of migraine and between aCL positive and negative migrainous patients. These data suggest that anticardiolipin antibodies are not involved in the pathogenesis of migraine complications.